Adani Ports and Special Economic Zone Ltd: Adani Ports and Special Economic Zone (APSEZ), one of the leading firms in post sector in India, will announce its Q4 number today. IIFL estimates that the company’s net profit is likely to dip to Rs. 656 crore, at a rate of 0.5% yoy; however, the same is expected to surge 2.8% qoq.
NALCO: The company has agreed to buy back 25 percent of its shares from the government, as per media reports.
Mahindra & Mahindra: The company reported its total sales stood at 41,863 units in April 2016 compared to 36,727 units in April 2015, recording a growth of 14%.
Future Group: Skechers India will increase its stake in its joint venture (JV) with Kishore Biyani from 49 per cent to 51 per cent, reports a business daily.
Blue Star: Blue Star said that it will challenge a Rs. 135.72 crore service tax and penalty imposed on it at an appropriate forum. The company termed it as a "patently erroneous" step by tax authorities.
TVS Motor Company: The company's total exports registered sales of 28,354 units in the month of April 2016 as against 32,426 units in April 2015.
Indraprastha Gas Ltd: The oil company has set up a record 72 CNG filling stations in first four months of 2016, to meet the rising demand for the fuel.
Maruti Suzuki Ltd: Maruti Suzuki Ltd has created a new management level as the country's largest car maker seeks to build management and leadership bandwidth for the future, reports a business daily.
IOC: Indian Oil Corporation Ltd has informed BSE that in accordance with the approval accorded by Cabinet Committee on Economic Affairs on May 13, 2013, Government of India (GOI) has offered 1,21,39,762 Equity Shares of Rs. 10/- each to the eligible employees of Indian Oil at a discounted price of Rs. 367.65 per share (5% discount to the cut off price of Rs. 387/- discovered through the Offer For Sale of equity shares of IndianOil carried out by GOI on August 24, 2015).
Hero MotoCorp: The company sold 612,739 units of two wheelers in April, registering a sturdy doubledigit growth of 15% over the corresponding month last year when the company had sold 533,305 units.
Alembic Pharma: The company has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Lacosamide Tablets, SO mg, 100 mg, lSO mg and 200 mg.
CCL Products: The company’s consolidated revenue stood at Rs. 264.49 crore, up 22.22% yoy and 24.21% qoq.
Apollo Hospitals: Apollo Hospitals has signed a memorandum of understanding with William Osler Health System (Osler) to collaborate on research and treatement services related to a range of diseases including Diabetes, Cardiovascular Diseases and Cancer.
Marksans Pharma: Marksans Pharma has received approval from the US health regulator for its Metformin Hydrochloride tablets, used for treatment of diabetes, in the American market.
No comments:
Post a Comment